Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nephromics (U.S. royalty obligation and worldwide diagnostics assets)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

U.S. royalty obligation and rights of worldwide diagnostics assets of Nephromics. The license is for tests related to the detection, monitoring and risk assessment of preeclampsia, a leading cause of maternal death.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Business Products and Services
Acquirer
Primary Office
  • Chestnut Hill, MA
  • United States

Nephromics (U.S. royalty obligation and worldwide diagnostics assets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nephromics (U.S. royalty obligation and worldwide diagnostics assets)‘s full profile, request access.

Request full access to PitchBook

Nephromics (U.S. royalty obligation and worldwide diagnostics assets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Nephromics (U.S. royalty obligation and worldwide diagnostics assets)‘s full profile, request access.

Request full access to PitchBook